MAPT and Alzheimer disease: Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative brain disorder characterized by extra-cellular accumulation of pathogenic amyloid-beta (Aβ) peptides, intracellular aggregation of hyperphosphorylated tau protein, and neuronal death [1, 2].